Description
REAGENT TESTING
First action · last action
2011-10-21 · 2011-10-21
Transactions
1
First transaction's obligation
$203,976
Base + all options value (sum of deltas)
$203,976
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P7126A
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-10-21+$203,976= $203,976
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-10-21 | +$203,976 | $203,976 | REAGENT TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JG5JF2JQJ121)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0884 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $23,706 | FY2026 |
| 36C24126N0887 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,003 | FY2026 |
| 36C24126N0852 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,023 | FY2026 |
| 36C25926N0415 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $113,988 | FY2026 |
| 36C26226N0611 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $1,339,307 | FY2026 |
| 36C24226N0602 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $326,624 | FY2026 |
Other recipients under Q301 from 603-LOUISVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24915F11360 | LABORATORY CORPORATION OF AMERICA | 603-LOUISVILLE | $782,998 | FY2015 |
| VA24914F4285 | DIAGNOSTICA STAGO INC | 603-LOUISVILLE | $51,269 | FY2014 |
| VA24913F0390 | LABORATORY CORPORATION OF AMERICA | 603-LOUISVILLE | $554,996 | FY2013 |
| VA24913J0202 | ROCHE DIAGNOSTICS CORPORATION | 603-LOUISVILLE | $72,218 | FY2013 |
| VA24913J0160 | TOSOH BIOSCIENCE, INC. | 603-LOUISVILLE | $38,091 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24912F0987_3600_V797P7126A_3600 · retrieved 2026-09-26.